Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Treasury Shares (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Treasury Shares for 16 consecutive years, with $112585.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares fell 66.81% to $112585.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $112585.0 through Dec 2025, down 66.81% year-over-year, with the annual reading at $112585.0 for FY2025, 66.81% down from the prior year.
  • Treasury Shares hit $112585.0 in Q4 2025 for Cumberland Pharmaceuticals, up from $3310.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $568181.0 in Q4 2021 to a low of $1800.0 in Q2 2025.
  • Historically, Treasury Shares has averaged $159000.5 across 5 years, with a median of $105821.0 in 2023.
  • Biggest five-year swings in Treasury Shares: skyrocketed 252.05% in 2023 and later plummeted 97.66% in 2025.
  • Year by year, Treasury Shares stood at $568181.0 in 2021, then plummeted by 30.35% to $395751.0 in 2022, then crashed by 34.16% to $260566.0 in 2023, then soared by 30.18% to $339200.0 in 2024, then crashed by 66.81% to $112585.0 in 2025.
  • Business Quant data shows Treasury Shares for CPIX at $112585.0 in Q4 2025, $3310.0 in Q3 2025, and $1800.0 in Q2 2025.